Unilateral retinoblastoma treated with IAC in 10 patients: demographics and tumour features
Patient | Age (months) | Sex | Affected eye | Treatment | ICRB | SRS | VS |
---|---|---|---|---|---|---|---|
1 | 20 | F | OS | Primary | E | + | + |
2 | 18 | M | OD | Primary | D | − | + |
3 | 22 | M | OD | Primary | E | + | + |
4 | 16 | M | OS | Primary | D | + | + |
5 | 11 | M | OS | Primary | D | + | + |
6 | 20 | M | OS | Salvage | D | − | + |
7 | 14 | F | OS | Primary | D | + | + |
8 | 24 | F | OD | Primary | E | + | + |
9 | 9 | F | OD | Salvage | D | − | + |
10 | 19 | M | OD | Salvage | D | − | + |
F, female; IAC, intra-arterial chemotherapy; ICRB, International Classification of Retinoblastoma; M, male; OD, right eye; OS, left eye; SRS, subretinal seeds; VS, vitreous seeds.